Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her views on Taiwan’s increasingly attractive clinical trial landscape. Li concludes by explaining how Taiwan and PPC can be a top partner to biotechs both from the APAC region or those looking to enter Asia.
Although we are not the largest by size, we make an important contribution to PPC through our talent, know-how, and strategic location
